Astrazeneca Share News (AZN)

AstraZeneca, Sanofi infant respiratory treatment gets US approval

(Sharecast News) - AstraZeneca and Sanofi's Beyfortus drug has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants, the two companies said on Tuesday.

LONDON BRIEFING: Ocado backs annual guidance as interim loss widens

(Alliance News) - Stocks in London are set to tread water on Tuesday, as investors look ahead to US corporate earnings and economic data.

Rishi Sunak to meet bosses at inaugural Business Council gathering

(Alliance News) - Bosses from AstraZeneca PLC, Alphabet Inc's Google, Shell PLC and other major companies will gather in Downing Street on Tuesday for the first meeting of Rishi Sunak's Business Council.

British prime minister seeks to win back corporate confidence with new business council

LONDON, July 17 (Reuters) - British Prime Minister Rishi Sunak will hold the first meeting of his new business council on Tuesday, in a bid to support his pledge to grow the economy and fend off attempts by the opposition Labour Party to win over the business community.

US FDA approves AstraZeneca and Sanofi's Beyfortus for RSV in infants

(Alliance News) - AstraZeneca PLC and Sanofi SA on Monday said the US Food & Drug Administration has approved the use of Beyfortus, or nirsevimab, in the US.

LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

LONDON MARKET OPEN: Stocks mixed ahead of US bank earnings

(Alliance News) - Stock prices in London opened mixed on Friday, after a strong run this week, while investors wait to see how major US banks fared in the second quarter of the year.

LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely

(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates.

Astra, Daiichi get China approval for Enhertu breast cancer treatment

(Alliance News) - Daiichi Sankyo Co Ltd on Wednesday its metastatic breast cancer treatment with AstraZeneca PLC was approved in China as a monotherapy for adult patients.

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

LONDON MARKET OPEN: FTSE 100 higher as UK banks pass BoE stress tests

(Alliance News) - European markets were trading higher on Wednesday, in a sign of cautious optimism ahead of US inflation data.

LONDON BRIEFING: UK banks pass stress test; Wetherspoon trades well

(Alliance News) - Stocks in London are called higher on Wednesday, ahead of US inflation data.

UK stocks: Even cheaper than normal

STOXX 600 up 0.1% after last week's rout

*

STOXX stabilises after last week's slide

STOXX 600 mostly steady after last week's rout

*

LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion

(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking.